I1QV34 Stock Overview
Engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
IQVIA Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$300.40 |
| 52 Week High | US$331.39 |
| 52 Week Low | US$260.74 |
| Beta | 1.51 |
| 11 Month Change | 0.33% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -18.50% |
| 5 Year Change | n/a |
| Change since IPO | 81.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| I1QV34 | BR Life Sciences | BR Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how I1QV34 performed against the BR Life Sciences industry.
Return vs Market: Insufficient data to determine how I1QV34 performed against the BR Market.
Price Volatility
| I1QV34 volatility | |
|---|---|
| I1QV34 Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in BR Market | 0% |
| 10% least volatile stocks in BR Market | 0% |
Stable Share Price: I1QV34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine I1QV34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 88,000 | Ari Bousbib | www.iqvia.com |
IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients’ outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.
IQVIA Holdings Inc. Fundamentals Summary
| I1QV34 fundamental statistics | |
|---|---|
| Market cap | R$212.66b |
| Earnings (TTM) | R$8.16b |
| Revenue (TTM) | R$88.91b |
26.1x
P/E Ratio2.4x
P/S RatioIs I1QV34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| I1QV34 income statement (TTM) | |
|---|---|
| Revenue | US$15.32b |
| Cost of Revenue | US$9.93b |
| Gross Profit | US$5.39b |
| Other Expenses | US$3.98b |
| Earnings | US$1.41b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.74 |
| Gross Margin | 35.17% |
| Net Profit Margin | 9.17% |
| Debt/Equity Ratio | 194.9% |
How did I1QV34 perform over the long term?
See historical performance and comparison